Searchable abstracts of presentations at key conferences in endocrinology

ea0021p215 | Endocrine tumours and neoplasia | SFEBES2009

Receptor-based scintigraphic imaging of insulinoma and glucagonoma in MEN-1

Sivappriyan Sivasubramaniam , Kurzawinski Tom , Bomanji Jamshed , Conway Gerard , Ahlquist James

Successful surgery for pancreatic neuro-endocrine tumours (NET) requires accurate tumour localisation. Interpretation of cross-sectional imaging is often difficult, particularly after pancreatic surgery. Imaging by somatostatin-receptor-scintigraphy with indium-labelled octreotide may be useful in identifying recurrent disease; however, octreotide scans may be negative in some pancreatic NET, due to a low level of expression of somatostatin receptors. The GLP-1 receptor is abu...

ea0006p41 | Endocrine tumours and neoplasia | SFE2003

Intraoperative parathyroid hormone (PTH) determinations

Honour J , Phillips I , Hodkinson R , Nelson D , Kurzawinski T

The outcome of parathyroid surgery is often not clear for at least 24 hours after an operation. Frozen section is not always helpful in distinguishing between adenoma and hyperplasia. Minimally invasive surgical techniques are being refined so the need for perioperative assurance about the effects of surgery has increased. PTH assays have been adapted to give results in less than 20 minutes. We have tested the value of intraoperative PTH measurements in 10 surgical cases under...

ea0050p266 | Neuroendocrinology and Pituitary | SFEBES2017

Patterns of recurrence, response to treatment and mortality in patients with malignant phaeochromocytomas and paragangliomas. – a single centre experience

Abdel-Aziz Tarek , Chung Teng-Teng , Bomanji Jamshed , Gaze Mark , Kurzawinski Tom

Introduction: Histology is a poor predictor of the malignant potential of phaeochromocytomas and paragangliomas (PPGL) and only the presence of distant metastasis confirms malignancy. This study reviews patterns of recurrence, treatment and mortality in patients with malignant PPGL presenting to our department at UCLH over 30 years.Materials and Methods: In our series of 128 patients with PPGL, 26 (20%) with maligna...

ea0050p266 | Neuroendocrinology and Pituitary | SFEBES2017

Patterns of recurrence, response to treatment and mortality in patients with malignant phaeochromocytomas and paragangliomas. – a single centre experience

Abdel-Aziz Tarek , Chung Teng-Teng , Bomanji Jamshed , Gaze Mark , Kurzawinski Tom

Introduction: Histology is a poor predictor of the malignant potential of phaeochromocytomas and paragangliomas (PPGL) and only the presence of distant metastasis confirms malignancy. This study reviews patterns of recurrence, treatment and mortality in patients with malignant PPGL presenting to our department at UCLH over 30 years.Materials and Methods: In our series of 128 patients with PPGL, 26 (20%) with maligna...

ea0086oc1.5 | Bone and Calcium | SFEBES2022

Can pre-operative treatment with intravenous bisphosphonates or cinacalcet have an effect on intra-operative parathyroid hormone measurements?

Wijewickrama Piyumi S A , Chung Teng-Teng , Abdel-Aziz Tarek E , Kurzawinski Tom R

Introduction: Primary hyperparathyroidism is a common endocrine disorder, surgery is curative. Patients with severe hypercalcemia receive cinacalcet or intravenous bisphosphonates as bridging. Intra-operative-parathyroid-hormone (IOPTH) measurement improves surgical accuracy. Bisphosphonates may increase PTH, while cinacalcet reduces it. The main aim was to assess the effect of zoledronate and cinacalcet on IOPTH.Method: Patients over 15-yo who underwent...

ea0067o36 | Oral Presentations | EYES2019

Unusual cause of gigantism – Growth hormone releasing hormone (GHRH)-secreting pancreatic neuroendocrine tumour in a patient with multiple endocrine neoplasia type 1 (MEN1)

Nadhamuni Vinaya Srirangam , Iacovazzo Donato , Evanson Jane , Trouillas Jacqueline , Kurzawinski Tom , Bhattacharya Satya , Korbonits Marta

Background: Gigantism is a rare condition with accelerated growth in childhood when the epiphyseal plates are not fused. Most cases are due to growth hormone (GH) secretion from a pituitary adenoma. Rarer causes of GH-related gigantism include somatotroph hyperplasia as part of McCune-Albright syndrome, Carney complex, X-linked acrogigantism or ectopic GHRH production.Case presentation: An 18-year-old male with c.249_252delGTCT;p.I85Sfs MEN1 mut...

ea0029p226 | Calcium & Vitamin D metabolism | ICEECE2012

Intraoperative parathormone monitoring allows successful minimally invasive parathyroidectomy in patients with non concordant preoperative imaging

Wignarajah P. , Paulo Prete F. , Philips I. , Smart J. , Kurzawinski T.

Introduction: Sestamibi (SM) and ultrasound (US) are routinely used for preoperative localisation of abnormal parathyroids in patients with hyperparathyroidism. Minimally invasive parathyroidectomy (MIP) is recommended if localisation is concordant, otherwise neck exploration is the method of choice.Aim: To assess whether introduction of intraoperative parathormone (IOPTH) monitoring allows us to perform MIP successfully in patients with non concordant f...

ea0018p32 | (1) | MES2008

Primary hyperparathyroidism presenting in pregnancy

Abbara Ali , Lecamwasam Varunika , Baynes Kevin , Bell Richard , Kurzawinski Thomas , Neila Mahadevan , Rafique Akkib , Kubba Faris

A 25-year-old pregnant lady presented to the accident and emergency department at 16 weeks gestation with intractable vomiting, weight loss and lethargy. She reported a 2 months history of hyperemesis gravidarum managed in the community prior to admission.She had no past medical history and her only medication was of a Polish antenatal vitamin containing 400 IU of Vitamin D (D2). Her blood biochemistry revealed a markedly raised corrected calcium at 3.57...

ea0007p280 | Clinical case reports | BES2004

Surgical treatment of children with neonatal severe hyperparathyroidism

Kurzawinski T , Fazel M , Spitz L , Waller S , Milroy E , W#T##Hoff|# , Dattani M

Familial Hypocalcuric Hypercalcaemia (FHH) is an autosomal dominant condition associated with inactivating mutations of the human calcium sensing receptor (CaSR) gene (heterozygotes). Neonatal Severe Primary Hyperparathyroidism (NSHPT) affects infants who inherit two such inactivating copies (homozygotes). NSHPT is frequently fatal without parathyroidectomy (PTx).Between 1984 and 2003 we have diagnosed and treated seven children (4M, 3F) with NSHPT. All ...

ea0094p188 | Bone and Calcium | SFEBES2023

A clinical audit on pre-operative work up and post-operative follow up in patients undergoing surgical management for primary hyperparathyroidism in a large tertiary Centre in the United Kingdom

Wijewickrama Piyumi , Simpson Helen , Baldeweg Stephanie , Srirangalingam Umasuthan , Abdel-Aziz Tarek , Kurzawinski Tom , Chung Teng-Teng

Background: Primary hyperparathyroidism (PHPT) is a common endocrine disorder. Aim of this audit was to assess clinical, biochemical parameters, localisation modalities and outcome in patients undergoing parathyroidectomy at University College London Hospital (UCLH).Methods: We audited all patients aged 15-years or above, undergoing parathyroidectomy, from 01-02-2018 to 31-12-2021 at UCLH via retrospective data collectio...